LGALS3BP and neuroblastoma: In the first study, they identified and isolated LGALS3BP from serum-free conditioned medium of several neuroblastoma cells, and proved that it stimulated expression of IL-6 followed by an increase in Erk1/2 activation in human bone marrow stromal cells (BMSC) expressing its receptor Galectin-3 [60].